Metraipolis › archive › dc_a5a08092e1d7
Treatment consequence and adverse events of cyclin-dependent kinase 4/6 inhibitors on patients with hormone receptor-positive, HER2-negative metastatic breast… — Europe PMC PMID:40922517
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40922517
- DOI
- 10.1080/07853890.2025.2557509
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T02:16:25.942Z
- SHA-256 of the archived text
af261f8513b1645d76dbb02babc31898e6627f439f4c76c02c74d19b8e5ace5c- Stable URL of this page
https://metraipolis.com/documento/dc_a5a08092e1d7
How to cite
Treatment consequence and adverse events of cyclin-dependent kinase 4/6 inhibitors on patients with hormone receptor-positive, HER2-negative metastatic breast… — Europe PMC PMID:40922517 — Europe PMC (en), https://europepmc.org/article/MED/40922517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5a08092e1d7 (Metraipolis archive dc_a5a08092e1d7, sha256 af261f8513b1645d76dbb02babc31898e6627f439f4c76c02c74d19b8e5ace5c)
BibTeX
@misc{dca5a08092e1d7,
title = {Treatment consequence and adverse events of cyclin-dependent kinase 4/6 inhibitors on patients with hormone receptor-positive, HER2-negative metastatic breast… — Europe PMC PMID:40922517},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40922517},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5a08092e1d7; sha256 af261f8513b1645d76dbb02babc31898e6627f439f4c76c02c74d19b8e5ace5c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40922517. Agents can read the archived copy with the MCP tool read_document.